Catalog No.:AA003JSO

21735-63-7 | 3-Phenyl-3-(2,2,2-trifluoro-acetylamino)-propionic acid

Name: Name:3-Phenyl-3-(2,2,2-trifluoro-acetylamino)-propionic acid
Brand: AABLOCKS
SKU: AA003JSO
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

97%

in stock

$45.00 $32.00

- +

97%

in stock

$137.00 $96.00

- +

25g

97%

in stock

$510.00 $357.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA003JSO

Chemical Name:

3-Phenyl-3-(2,2,2-trifluoro-acetylamino)-propionic acid

CAS Number:

21735-63-7

Molecular Formula:

C11H10F3NO3

Molecular Weight:

261.1972

MDL Number:

MFCD00451455

SMILES:

OC(=O)CC(c1ccccc1)NC(=O)C(F)(F)F

Properties

BP:

392.5±42.0°C at 760 mmHg

Form:

Solid

Storage:

Keep in dry area;Room Temperature;

Computed Properties

Complexity:

311

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

Undefined Atom Stereocenter Count:

XLogP3:

1.7

Downstream Synthesis Route

100-02-7

21735-63-7

64482-08-2

[1]Reed;Katzenellenbogen[JournalofMedicinalChemistry,1991,vol.34,#3,p.1162-1176]

21735-63-7

117291-26-6

[1]Luan,Feng;Cordeiro,M.NatáliaD.S.;Alonso,Nerea;García-Mera,Xerardo;Caamaño,Olga;Romero-Duran,FranciscoJ.;Yañez,Matilde;González-Díaz,Humberto[BioorganicandMedicinalChemistry,2013,vol.21,#7,p.1870-1879]

[2]Quermonne;Dallemagne;Louchahi-Raoul;Pilo;Rault;Robba[EuropeanJournalofMedicinalChemistry,1992,vol.27,#9,p.961-965]

[3]CurrentPatentAssignee:NRGTHERAPEUTICS-WO2022/49377,2022,A1Locationinpatent:Page/Pagecolumn74

[4]CurrentPatentAssignee:NRGTHERAPEUTICS-WO2022/49377,2022,A1Locationinpatent:Page/Pagecolumn74

[5]CurrentPatentAssignee:NRGTHERAPEUTICS-WO2022/49377,2022,A1Locationinpatent:Page/Pagecolumn74

[6]Rault,S.;Pilo,J.C.;Dallemagne,P.;Foloppe,M.P.;Robba,M.[BulletindelaSocieteChimiquedeFrance,1990,#2,p.316-323]

[7]Rault,Sylvain;Dallemagne,Patrick;Robba,Max[BulletindelaSocieteChimiquedeFrance,1987,#6,p.1079-1083]

[8]Renault,Olivier;Guillon,Jean;Dallemagne,Patrick;Rault,Sylvain[TetrahedronLetters,2000,vol.41,#5,p.681-683]

[9]Leflemme,Nicolas;Dallemagne,Patrick;Rault,Sylvain[TetrahedronLetters,2001,vol.42,#51,p.8997-8999]

[10]Locationinpatent:schemeortableWu,Dongpei;Pontillo,Joseph;Ching,Brett;Hudson,Sarah;Gao,Yinghong;Fleck,BethA.;Gogas,Kathleen;Wade,WarrenS.[BioorganicandMedicinalChemistryLetters,2008,vol.18,#14,p.4224-4227]

21735-63-7

3-Phenyl-3-(2,2,2-trifluoro-acetylamino)-propionylazide

[1]Rault,Sylvain;Tembo,OlivierN.;Dallemagne,Patrick;Robba,Max[Heterocycles,1991,vol.32,#7,p.1301-1305]

5661-55-2

76-05-1

21735-63-7

[1]Mattingly;Miller[JournalofOrganicChemistry,1981,vol.46,#8,p.1557-1564]

3646-50-2

407-25-0

21735-63-7

[1]Quermonne;Dallemagne;Louchahi-Raoul;Pilo;Rault;Robba[EuropeanJournalofMedicinalChemistry,1992,vol.27,#9,p.961-965]

[2]Luan,Feng;Cordeiro,M.NatáliaD.S.;Alonso,Nerea;García-Mera,Xerardo;Caamaño,Olga;Romero-Duran,FranciscoJ.;Yañez,Matilde;González-Díaz,Humberto[BioorganicandMedicinalChemistry,2013,vol.21,#7,p.1870-1879]

[3]CurrentPatentAssignee:NRGTHERAPEUTICS-WO2022/49377,2022,A1Locationinpatent:Page/Pagecolumn74

[4]CurrentPatentAssignee:NRGTHERAPEUTICS-WO2022/49377,2022,A1Locationinpatent:Page/Pagecolumn74

[5]CurrentPatentAssignee:NRGTHERAPEUTICS-WO2022/49377,2022,A1Locationinpatent:Page/Pagecolumn74

[6]Rault,S.;Pilo,J.C.;Dallemagne,P.;Foloppe,M.P.;Robba,M.[BulletindelaSocieteChimiquedeFrance,1990,#2,p.316-323]

[7]Reed;Katzenellenbogen[JournalofMedicinalChemistry,1991,vol.34,#3,p.1162-1176]

[8]Rault,Sylvain;Dallemagne,Patrick;Robba,Max[BulletindelaSocieteChimiquedeFrance,1987,#6,p.1079-1083]

[9]Renault,Olivier;Guillon,Jean;Dallemagne,Patrick;Rault,Sylvain[TetrahedronLetters,2000,vol.41,#5,p.681-683]

[10]Leflemme,Nicolas;Dallemagne,Patrick;Rault,Sylvain[TetrahedronLetters,2001,vol.42,#51,p.8997-8999]

[11]Cronin,SarahA.;Connon,StephenJ.[OrganicandBiomolecularChemistry,2021,vol.19,#34,p.7348-7352]

Literature

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS